Publication | Open Access
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients
80
Citations
20
References
2013
Year
EGFR mutations detected on cytology specimens by a centralized laboratory can predict TKI treatment response equally well as mutations identified on histology samples.
| Year | Citations | |
|---|---|---|
Page 1
Page 1